Literature DB >> 21626409

Breaking T cell tolerance to beta cell antigens by merocytic dendritic cells.

Jonathan D Katz1, Edith M Janssen.   

Abstract

In type 1 diabetes (T1D), a break in central and peripheral tolerance results in antigen-specific T cells destroying insulin-producing, pancreatic beta cells. Herein, we discuss the critical sub-population of dendritic cells responsible for mediating both the cross-presentation of islet antigen to CD8(+) T cells and the direct presentation of beta cell antigen to CD4(+) T cells. These cells, termed merocytic dendritic cells (mcDC), are more numerous in non-obese diabetic (NOD), and antigen-loaded mcDC rescue CD8(+) T cells from peripheral anergy and deletion, and stimulate islet-reactive CD4(+) T cells. When purified from the pancreatic lymph nodes of overtly diabetic NOD mice, mcDC can break peripheral T cell tolerance to beta cell antigens in vivo and induce rapid onset T cell-mediated T1D in young NOD mouse. Thus, the mcDC subset appears to represent the long-sought critical antigen-presenting cell responsible for breaking peripheral tolerance to beta cell antigen in vivo.

Entities:  

Mesh:

Year:  2011        PMID: 21626409      PMCID: PMC3855359          DOI: 10.1007/s00018-011-0730-6

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  103 in total

Review 1.  Diabetogenic T-cell clones.

Authors:  K Haskins; D Wegmann
Journal:  Diabetes       Date:  1996-10       Impact factor: 9.461

2.  The role of CD8+ T cells in the initiation of insulin-dependent diabetes mellitus.

Authors:  B Wang; A Gonzalez; C Benoist; D Mathis
Journal:  Eur J Immunol       Date:  1996-08       Impact factor: 5.532

3.  Beta cell apoptosis in T cell-mediated autoimmune diabetes.

Authors:  M O Kurrer; S V Pakala; H L Hanson; J D Katz
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-07       Impact factor: 11.205

4.  MHC class I-mediated antigen presentation and induction of CD8+ cytotoxic T-cell responses in autoimmune diabetes-prone NOD mice.

Authors:  D V Serreze; W S Gallichan; D P Snider; K Croitoru; K L Rosenthal; E H Leiter; G J Christianson; M E Dudley; D C Roopenian
Journal:  Diabetes       Date:  1996-07       Impact factor: 9.461

5.  Immunohistochemical characterization of monocytes-macrophages and dendritic cells involved in the initiation of the insulitis and beta-cell destruction in NOD mice.

Authors:  A Jansen; F Homo-Delarche; H Hooijkaas; P J Leenen; M Dardenne; H A Drexhage
Journal:  Diabetes       Date:  1994-05       Impact factor: 9.461

6.  Major histocompatibility complex class I-deficient NOD-B2mnull mice are diabetes and insulitis resistant.

Authors:  D V Serreze; E H Leiter; G J Christianson; D Greiner; D C Roopenian
Journal:  Diabetes       Date:  1994-03       Impact factor: 9.461

Review 7.  Multifactorial inheritance in type 1 diabetes.

Authors:  H J Cordell; J A Todd
Journal:  Trends Genet       Date:  1995-12       Impact factor: 11.639

Review 8.  Checkpoints in the progression of autoimmune disease: lessons from diabetes models.

Authors:  I André; A Gonzalez; B Wang; J Katz; C Benoist; D Mathis
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

9.  Dynamics of beta-cell mass in the growing rat pancreas. Estimation with a simple mathematical model.

Authors:  D T Finegood; L Scaglia; S Bonner-Weir
Journal:  Diabetes       Date:  1995-03       Impact factor: 9.461

10.  Beta-cell-cytotoxic CD8+ T cells from nonobese diabetic mice use highly homologous T cell receptor alpha-chain CDR3 sequences.

Authors:  P Santamaria; T Utsugi; B J Park; N Averill; S Kawazu; J W Yoon
Journal:  J Immunol       Date:  1995-03-01       Impact factor: 5.422

View more
  5 in total

1.  Functional specialization of islet dendritic cell subsets.

Authors:  Na Yin; Jiangnan Xu; Florent Ginhoux; Gwendalyn J Randolph; Miriam Merad; Yaozhong Ding; Jonathan S Bromberg
Journal:  J Immunol       Date:  2012-04-16       Impact factor: 5.422

Review 2.  Of the multiple mechanisms leading to type 1 diabetes, T cell receptor revision may play a prominent role (is type 1 diabetes more than a single disease?).

Authors:  D H Wagner
Journal:  Clin Exp Immunol       Date:  2016-07-25       Impact factor: 4.330

3.  Reversal of New-Onset Type 1 Diabetes With an Agonistic TLR4/MD-2 Monoclonal Antibody.

Authors:  Kyle J Bednar; Hiroki Tsukamoto; Kritika Kachapati; Shoichiro Ohta; Yuehong Wu; Jonathan D Katz; Dana P Ascherman; William M Ridgway
Journal:  Diabetes       Date:  2015-06-30       Impact factor: 9.337

Review 4.  A Comprehensive Review of the Evolution of Insulin Development and Its Delivery Method.

Authors:  Vaisnevee Sugumar; Kuan Ping Ang; Ahmed F Alshanon; Gautam Sethi; Phelim Voon Chen Yong; Chung Yeng Looi; Won Fen Wong
Journal:  Pharmaceutics       Date:  2022-07-04       Impact factor: 6.525

Review 5.  Dendritic cell subsets in type 1 diabetes: friend or foe?

Authors:  Penelope A Morel
Journal:  Front Immunol       Date:  2013-12-06       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.